Oat1/3 restoration protects against renal damage after ischemic AKI

American Journal of Physiology - Renal Physiology

Volumn 308, Issue 3, 2015, Pages F198-F208

  Schneider, R ^a   Meusel, M ^a   Betz, B ^a   Held, C ^a   Moller Ehrlich K ^b   Buttner Herold M ^c   Wanner, C ^a   Gekle, M ^d   Sauvant, C ^d  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Cyclooxygenase (COX); Glomerular filtration rate (GFR); Ischemia; Ischemic acute kidney injury (iAKI); Kidney cortex; Monocytes macrophages; Renal organic anion transport; Renal plasma flow (RPF); Reperfusion

Indexed keywords

INDOMETACIN; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; ORGANIC ANION TRANSPORTER 1; ORGANIC ANION TRANSPORTER 3; PROBENECID; PROSTAGLANDIN E2; ORGANIC ANION TRANSPORTER; SLC22A6 PROTEIN, RAT;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CELL STRUCTURE; CLEARANCE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; FEMALE; GLOMERULUS FILTRATION RATE; INFLAMMATION; KIDNEY CORTEX; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY PERFUSION; LOW DRUG DOSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; ACUTE KIDNEY INJURY; ANIMAL; DISEASE MODEL; DRUG EFFECTS; ISCHEMIA; KIDNEY; METABOLISM; PATHOPHYSIOLOGY; REPERFUSION INJURY; SPRAGUE DAWLEY RAT;

ACUTE KIDNEY INJURY; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; GLOMERULAR FILTRATION RATE; INDOMETHACIN; ISCHEMIA; KIDNEY; ORGANIC ANION TRANSPORT PROTEIN 1; ORGANIC ANION TRANSPORTERS, SODIUM-INDEPENDENT; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 84922234611     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00160.2014     Document Type: Article

References (36)

1. Betz B, Schneider R, Kress T, Schick MA, Wanner C, Sauvant C. Rosiglitazone affects nitric oxide synthases and improves renal outcome in a rat model of severe ischemia/reperfusion injury. PPAR Res 2012: 2012.
2. Bischoff A, Bucher M, Gekle M, Sauvant C. Differential effect of COX1 and COX2 inhibitors on renal outcomes following ischemic acute kidney injury. Am J Nephrol 40: 1-11, 2014.
3. Bischoff A, Bucher M, Gekle M, Sauvant C. PAH clearance after renal ischemia and reperfusion is a function of impaired expression of basolateral Oat1 and Oat3. Physiol Rep 2: e00243, 2014.
4. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
5. Burckhardt BC, Burckhardt G. Transport of organic anions across the basolateral membrane of proximal tubule cells. Rev Physiol Biochem Pharmacol 146: 95-158, 2003.
6. Corrigan G, Ramaswamy D, Kwon O, Sommer FG, Alfrey EJ, Dafoe DC, Olshen RA, Scandling JD, Myers BD. PAH extraction and estimation of plasma flow in human postischemic acute renal failure. Am J Physiol Renal Physiol 277: F312-F318, 1999.
7. Dantzler WH. Renal organic anion transport: a comparative and cellular perspective. Biochim Biophys Acta 1566: 169-181, 2002.
8. Dantzler WH, Wright SH. The molecular and cellular physiology of basolateral organic anion transport in mammalian renal tubules. Biochim Biophys Acta 1618: 185-193, 2003.
9. Di Giusto G, Anzai N, Endou H, Torres AM. Elimination of organic anions in response to an early stage of renal ischemia-reperfusion in the rat: role of basolateral plasma membrane transporters and cortical renal blood flow. Pharmacology 81: 127-136, 2008.
10. El-Sheikh AA, Masereeuw R, Russel FG. Mechanisms of renal anionic drug transport. Eur J Pharmacol 585: 245-255, 2008.
11. Emanuelsson BM, Paalzow LK. Dose-dependent pharmacokinetics of probenecid in the rat. Biopharm Drug Dispos 9: 59-70, 1988.
12. Feitoza CQ, Camara NOS, Pinheiro HS, Goncalves GM, Cenedeze MA, Pacheco-Silva A, Santos OFP. Cyclooxygenase 1 and/or 2 blockade ameliorates the renal tissue damage triggered by ischemia and reperfusion injury. Int Immunopharmacol 5: 79-84, 2005.
13. Feitoza CQ, Sanders H, Cenedeze M, Camara NOS, Pacheco-Silva A. Pretreatment with indomethacin protects from acute renal failure following ischemia-reperfusion injury. Transplant Proc 34: 2979-2980, 2002.
14. Friis C. Renal transport and metabolism of xenobiotics. Acta Vet Scand 32: 33-43, 1991.
15. Goligorsky MS, Brodsky SV, Noiri E. Nitric oxide in acute renal failure: NOS versus NOS. Kidney Int 61: 855-861, 2002.
16. Guan Z, Gobe G, Willgoss D, Endre ZH. Renal endothelial dysfunction and impaired autoregulation after ischemia-reperfusion injury result from excess nitric oxide. Am J Physiol Renal Physiol 291: F619-F628, 2006.
17. Kimura H, Takeda M, Narikawa S, Enomoto A, Ichida K, Endou H. Human organic anion transporters and human organic cation transporters mediate renal transport of prostaglandins. J Pharmacol Exp Ther 301: 293-298, 2002.
18. Kusuhara H, Sekine T, Utsunomiya-Tate N, Tsuda M, Kojima R, Cha SH, Sugiyama Y, Kanai Y, Endou H. Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain. J Biol Chem 274: 13675-13680, 1999.
19. Matsuzaki T, Watanabe H, Yoshitome K, Morisaki T, Hamada A, Nonoguchi H, Kohda Y, Tomita K, Inui K, Saito H. Downregulation of organic anion transporters in rat kidney under ischemia/reperfusion-induced acute renal failure. Kidney Int 71: 539-547, 2007.
20. Perri D, Ito S, Rowsell V, Shear NH. The kidney-the body's playground for drugs: an overview of renal drug handling with selected clinical correlates. Can J Clin Pharmacol 10: 17-23, 2003.
21. Raff U, Schneider R, Gambaryan S, Seibold S, Reber M, Vornberger N, Freund R, Schramm L, Wanner C, Galle J. L-arginine does not affect renal morphology and cell survival in ischemic acute renal failure in rats. Nephron Physiol 101: p39-p50, 2005.
22. Raspe C, Hocherl K, Rath S, Sauvant C, Bucher M. NF-kappaBmediated inverse regulation of fractalkine and CX3CR1 during CLPinduced sepsis. Cytokine 61: 97-103, 2013.
23. Sauvant C, Holzinger H, Gekle M. Prostaglandin E2 inhibits its own renal transport by downregulation of organic anion transporters rOAT1 and rOAT3. J Am Soc Nephrol 17: 46-53, 2006.
24. Sauvant C, Schneider R, Holzinger H, Renker S, Wanner C, Gekle M. Implementation of an in vitro model system for investigation of reperfusion damage after renal ischemia. Cell Physiol Biochem 24: 567-576, 2009.
25. Sauvant C, Schneider R, Holzinger H, Renker S, Wanner C, Gekle M. Indomethacin corrects alterations associated with ischemia/reperfusion in an in vitro proximal tubular model. Am J Nephrol 32: 57-65, 2010.
26. Sauvant C, Schneider R, Betz B, Otremba M, Fischer H, Holzinger H, Wanner C, Galle J, Gekle M. OAT1 and OAT3 are down regulated after ischemic acute renal failure in rats. Acta Physiol 189: 104, 2007.
27. Schneider R, Meusel M, Renker S, Bauer C, Holzinger H, Roeder M, Wanner C, Gekle M, Sauvant C. Low-dose indomethacin after ischemic acute kidney injury prevents downregulation of Oat1/3 and improves renal outcome. Am J Physiol Renal Physiol 297: F1614-F1621, 2009.
28. Schneider R, Sauvant C, Betz B, Otremba M, Fischer D, Holzinger H, Wanner C, Galle J, Gekle M. Downregulation of organic anion transporters OAT1 and OAT3 correlates with impaired secretion of paraaminohippurate after ischemic acute renal failure in rats. Am J Physiol Renal Physiol 292: F1599-F1605, 2007.
29. Sekine T, Miyazaki H, Endou H. Molecular physiology of renal organic anion transporters. Am J Physiol Renal Physiol 290: F251-F261, 2006.
30. Sheridan AM, Bonventre JV. Cell biology and molecular mechanisms of injury in ischemic acute renal failure. Curr Opin Nephrol Hypertens 9: 427-434, 2000.
31. Sung FL, Zhu TY, Au-Yeung KK, Siow YL, OK. Enhanced MCP-1 expression during ischemia/reperfusion injury is mediated by oxidative stress and NF-kappaB. Kidney Int 62: 1160-1170, 2002.
32. + gradient. Am J Physiol Renal Physiol 284: F763-F769, 2003.
33. Tokuyama H, Hayashi K, Matsuda H, Kubota E, Honda M, Okubo K, Ozawa Y, Saruta T. Stenosis-dependent role of nitric oxide and prostaglandins in chronic renal ischemia. Am J Physiol Renal Physiol 282: F859-F865, 2002.
34. Tokuyama H, Hayashi K, Matsuda H, Kubota E, Honda M, Okubo K, Takamatsu I, Ozawa Y, Saruta T. Role of nitric oxide and prostaglandin E2 in acute renal hypoperfusion. Nephrology (Carlton) 8: 65-71, 2003.
35. Van Montfoort JE, Hagenbuch B, Groothuis GM, Koepsell H, Meier PJ, Meijer DK. Drug uptake systems in liver and kidney. Curr Drug Metab 4: 185-211, 2003.
36. Wright SH, Dantzler WH. Molecular and cellular physiology of renal organic cation and anion transport. Physiol Rev 84: 987-1049, 2004.